1. Home
  2. BNR vs OCCI Comparison

BNR vs OCCI Comparison

Compare BNR & OCCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Burning Rock Biotech Limited

BNR

Burning Rock Biotech Limited

HOLD

Current Price

$9.67

Market Cap

76.5M

Sector

Health Care

ML Signal

HOLD

Logo OFS Credit Company Inc.

OCCI

OFS Credit Company Inc.

HOLD

Current Price

$2.59

Market Cap

74.6M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNR
OCCI
Founded
2014
N/A
Country
China
United States
Employees
N/A
N/A
Industry
Medical Specialities
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
76.5M
74.6M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
BNR
OCCI
Price
$9.67
$2.59
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
20.8K
272.0K
Earning Date
06-05-2026
12-11-2023
Dividend Yield
N/A
24.32%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$111.65
N/A
Revenue Next Year
N/A
$10.19
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.51
$2.42
52 Week High
$41.72
$6.29

Technical Indicators

Market Signals
Indicator
BNR
OCCI
Relative Strength Index (RSI) 49.24 35.28
Support Level $8.05 $2.42
Resistance Level $9.90 $2.65
Average True Range (ATR) 0.82 0.12
MACD 0.52 0.01
Stochastic Oscillator 84.46 33.04

Price Performance

Historical Comparison
BNR
OCCI

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreements with the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, the In-hospital business, & Pharma research & development services. It generates the majority of its revenue from the Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, & others.

About OCCI OFS Credit Company Inc.

OFS Credit Co Inc is a non-diversified, closed-end management investment company. Its investment objective is to generate current income, with a secondary objective to generate capital appreciation through investment in collateralized loan obligation (CLO) equity and debt securities. The company invests in floating rate credit instruments and other structured credit investments, including collateralized loan obligation (CLO) debt and subordinated (i.e., residual or equity) securities; traditional corporate credit investments, including leveraged loans and high yield bonds; opportunistic credit investments, including stressed and distressed credit situations and long/short credit investments; and other credit-related instruments.

Share on Social Networks: